Zevra Therapeutics Quote - ZVRA

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

7.65

Bid

7.47

Offer

8.19

Volume

0.00 Day's Range 0.00

4.20 52 Week Range 9.76

Market Cap

408.326M

Previous Close

7.65

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

538,757

Shares Outstanding

53,375,932

Dividend Yield

PE Ratio

-8.87

Earnings Per Share (EPS)

-0.86

Revenue

27.46M

Net Profit

-46.05M

Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and ... Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and commercial stage assets. It employs its LAT platform technology to create a portfolio of approved products. Its product candidates include Arimoclomol, KP1077IH, KP1077N and AZSTARYS. Arimoclomol is an orally delivered, investigational product candidate being developed for Niemann-Pick disease type C (NPC). KP1077 is the Company's lead clinical development product candidate, which is being developed as a treatment for idiopathic hypersomnia (IH) and narcolepsy. KP1077 is comprised solely of serdexmethylphenidate (SDX), the Company's prodrug of d-methylphenidate (d-MPH). AZSTARYS is a prodrug for the treatment of ADHD in patients aged six years or older. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kempharm.com

Headquarters

Wilmington, Delaware, USA

Founded

Zevra Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZVRA. The last closing price for Zevra Therapeutics was US$7.65. Over the last year, Zevra Therapeutics shares have traded in a share price range of US$ 4.20 to US$ 9.76.

Zevra Therapeutics currently has 53,375,932 shares in issue. The market capitalisation of Zevra Therapeutics is US$408.33 million. Zevra Therapeutics has a price to earnings ratio (PE ratio) of -8.87.

Overall Flow

Bearish

Net Premium

-209k

Calls / Puts

0.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.46	-5.67200986436	8.11	8.24	7.4801	581020	7.87853382	CS
4	-0.78	-9.25266903915	8.43	8.72	7.4801	443430	8.01473428	CS
12	-1.26	-14.1414141414	8.91	9.76	7.4801	538757	8.61206361	CS
26	0.09	1.19047619048	7.56	9.76	6.5	799414	7.97406472	CS
52	2	35.3982300885	5.65	9.76	4.2	559523	7.32422051	CS
156	2	35.3982300885	5.65	9.76	3.89	399390	6.73042172	CS
260	2	35.3982300885	5.65	9.76	3.89	399390	6.73042172	CS

ZVRA - Frequently Asked Questions (FAQ)

What is the current Zevra Therapeutics share price?

The current share price of Zevra Therapeutics is US$ 7.65

How many Zevra Therapeutics shares are in issue?

Zevra Therapeutics has 53,375,932 shares in issue

What is the market cap of Zevra Therapeutics?

The market capitalisation of Zevra Therapeutics is USD 408.33M

What is the 1 year trading range for Zevra Therapeutics share price?

Zevra Therapeutics has traded in the range of US$ 4.20 to US$ 9.76 during the past year

What is the PE ratio of Zevra Therapeutics?

The price to earnings ratio of Zevra Therapeutics is -8.87

What is the cash to sales ratio of Zevra Therapeutics?

The cash to sales ratio of Zevra Therapeutics is 14.87

What is the reporting currency for Zevra Therapeutics?

Zevra Therapeutics reports financial results in USD

What is the latest annual turnover for Zevra Therapeutics?

The latest annual turnover of Zevra Therapeutics is USD 27.46M

What is the latest annual profit for Zevra Therapeutics?

The latest annual profit of Zevra Therapeutics is USD -46.05M

What is the registered address of Zevra Therapeutics?

The registered address for Zevra Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Zevra Therapeutics website address?

The website address for Zevra Therapeutics is www.kempharm.com

Which industry sector does Zevra Therapeutics operate in?

Zevra Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EVAXEvaxion Biotech AS	US$ 4.07 (69.58%)	14.37M
PTIRGraniteShares 2X Long PLTR Daily ETF	US$ 212.79 (37.01%)	80.37k
PLTUDirexion DAily PLTR Bull 2X Shares	US$ 45.09 (36.68%)	114.3k
IVVDInvivyd Inc	US$ 1.34 (26.42%)	11.95M
SUGPSU Group Holdings Ltd	US$ 1.20 (21.24%)	1
UOKAMDJM Ltd	US$ 0.1685 (-29.20%)	1.05M
UPCUniverse Pharmaceuticals Inc	US$ 0.3051 (-26.90%)	113.8k
TENXTenax Therapeutics Inc	US$ 4.48 (-24.71%)	98
EJHE Home Household Service Holdings Ltd	US$ 0.7794 (-23.59%)	41.66k
MYSZMy Size Inc	US$ 1.67 (-21.23%)	276
EVAXEvaxion Biotech AS	US$ 4.07 (69.58%)	14.37M
IVVDInvivyd Inc	US$ 1.34 (26.42%)	11.95M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.1639 (-15.91%)	3.61M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0405 (-12.34%)	3.48M
PLTRPalantir Technologies Inc	US$ 99.62 (18.96%)	2.69M